Director, Nutrition Science, Pharmavite
Over 100 presentations will be given at the 2019 US series. Over two days discover more about novel research and development trends, explore business and commercialisation strategies, and discover how to translate findings into viable products through collaborative partnerships and funding opportunities. With a focus on metabolic functioning, autoimmune and inflammatory disorders, the gut-brain axis and the relationship between the microbiome and cancer, explore the composition of the gut microbiome, and the tools and technologies used to study microbial communities. This meeting has a reputation for providing an outstanding networking experience in which new collaborations between industry and academia are forged to better translate research into clinical trials. Plus, you will have ample opportunity to review more than 40 poster presentations and meet with 30+ exhibitors showcasing the latest products and services.
“the talks I went to had real content (data, innovative ideas, business impact) and the speakers had the right expertise in the field”
“I meet with people representing different areas in this growing industry, including academia, pharma, and other companies”
“deeper understanding of product concepts – especially clinical relevance and application to health outcomes”
“excellent speakers … a mix of research and business focussed talks”
The 7th Microbiome R&D & Business Collaboration Forum is one of four co-located meetings forming the Microbiome & Probiotics Series: USA.
2019 featured speakers – Our full speaker panel can be found here
Assistant Professor of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Professor, Director, Foods and Health Institute, Department of Food Science & Technology, UC Davis
This programme creates a collaborative environment in which you can create enduring relationships across the full range of microbiome and probiotics research.